Stericycle Inc. (SRCL) Pops 2.59% for January 29

Equities Staff |

One of the S&P 500’s big winners for Friday January 29 was Stericycle Inc. (SRCL) as the company’s stock climbed 2.59% to $119.96 on volume of 431,838 shares.

The stock opened at $117.19 and saw an intraday low of $117.00 and an intraday high of $120.09. All told, the day saw a per-share gain of $3.03. The stock’s average daily volume of 919,435 and 84.98 million shares outstanding. Stericycle Inc. now has a 50-day SMA is $118.96 and 200-day SMA is $132.76, and it has a 52-week high of $151.57 and a 52-week low of $110.56.

Stericycle Inc is engaged in providing regulated and compliance solutions to healthcare and commercial businesses. This includes the collection and processing of specialized waste for disposal, and a variety of training, and consulting.

Based out of Lake Forest, IL, Stericycle Inc. has 18,656 employees and, after today’s trading, reached a market cap of $10.19 billion. The stock’s P/E Ratio is 37.9. Its P/S ratio is 4.74, P/B ratio is 3.75, and P/FCF ratio is 84.8.

For a complete fundamental analysis analysis of Stericycle Inc., check out Equities.com’s Stock Valuation Analysis report for SRCL. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Pinterest

Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…

D-Wave

D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…